Skip to main content

Stack David M's Form 4 filing

Pacira BioSciences, Inc. (PCRX) · filed Jun 8, 2022

Accession no.
0001209191-22-035235
Filed
Jun 8, 2022
Trade date
Jun 6-8, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.56M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stack David MCIK 0001204788Director, Officer (CEO and Chairman)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 6, 2022Common StockSSaleDisposed−11,965$61.37−$734,292.05156,079Direct
Jun 8, 2022Common StockSSaleDisposed−7,039$59.10−$416,004.9149,040Direct
Jun 8, 2022Common StockSSaleDisposed−5,006$60.33−$302,011.98144,034Direct
Jun 8, 2022Common StockSSaleDisposed−1,282$61.31−$78,599.42142,752Direct
Jun 8, 2022Common StockSSaleDisposed−501$61.96−$31,041.96142,251Direct
Jun 8, 2022Common StockAGrant or awardAcquired+21,500$0.00$0163,751Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 8, 2022Common StockAGrant or awardAcquired+160,900$0.00$0160,900Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)